ClotCare: Blood Clots, Stroke, Heart Attack
Monday, March 27, 2017
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

National Alliance for Thrombosis and Thrombophilia (NATT) - A Patient Advocacy Group

October, 2005

The National Alliance for Thrombosis and Thrombophilia (NATT) has provided us with information about their organization. A summary of NATT's history, goals, activities, and priorities is below. To learn more about NATT, you may visit the organization's website at http://www.stoptheclot.org.


Mark Jablonski1, Lori Preston2 and Stephan Moll3

1President of NATT, Chicago; jablonskithrombo@yahoo.com
2Vice-President and Chair of Communications Subcommittee of NATT, Baltimore; LPreston@keelan.com
3Chairman of NATT's Medical and Scientific Advisory Board; UNC Chapel Hill; smoll@med.unc.edu

History

In August 2003 a patient advocacy group for thrombosis and thrombophilia formed, NATT (National Alliance for Thrombosis and Thrombophilia). The CDC under the leadership of Dr. Bruce Evatt had long seen the need for a national consumer advocacy group to (a) lobby in Washington for more funding for thrombosis and hemostasis centers, so that better care could be provided to patients suffering from thrombosis and thrombophilia, and (b) raise the awareness of these disorders in the public and the medical community so that more physicians would find coagulation a worthwhile subspecialty field to go into. Over a period of 2 years the CDC had explored options for such a patient advocacy group through patient focus group meetings and discussions with health care providers and existing patient interest groups. This fostered and eventually led to the formation of the independent and volunteer patient interest group NATT in August 2003. NATT was incorporated in December 2003 and received non-profit 501c3 status in December 2004.

NATT's Goals

NATT is a community-based, volunteer organization. Board members are individuals affected personally or through family members by thrombosis and/or thrombophilia. NATT's goals are to (a) promote greater awareness of thrombosis and thrombophilia in the public and health care provider community, (b) to ensure better diagnosis and treatment of patients with blood clots, and (c) to foster research on these disorders. The long-term objectives are to

  • create a grassroots advocacy network
  • pursue a national policy agenda
  • develop and promote standards of care
  • increase the availability of high quality care
  • promote educational activities
  • develop patient support groups throughout the country
  • encourage, enable and initiate clinical and basic research

NATT's Activities Until Now

  • NATT was incorporated in December 2003
  • received non-profit 501c3 status in December 2004
  • launched a website: http://www.nattinfo.org
  • recruited a Medical and Scientific Advisory Board Members (MASAB)
  • met with the CDC and developed a research project to determine the specific needs of patients who have suffered from or are at risk for thrombosis
  • sent a letter to all Congressmen and Senators introducing NATT
  • attended a workshop in Washington organized by ASH for NATT in May 2004
  • met with NHLBI in February 2005 to discuss thrombosis/thrombophilia research needs
  • identified existing educational materials for patients and materials still needed; created materials in fields where gaps had been determined
  • organized 4 regional patient education seminars (Denver, Charlotte, Detroit, Chicago) and co-sponsored a seminar in Pittsburgh, PA
  • Published and sent-out its first newsletter, available at http://www.nattinfo.org/newsletter%20spring%202005.pdf

NATT's 2005/2006 Priorities:

  • Organize and co-sponsor additional patient education seminars
  • create further thrombosis/thrombophilia educational materials
  • establish a Q/A section on its website
  • bring out further newsletters (next in November 2005)
  • continue advocacy efforts in Washington
  • start defining standards of care for thrombosis/thrombophilia and identify research priorities
  • increase fundraising efforts and secure regular funding for the organization
  • reach more patients and their families
Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org.

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

Seeking Patients Taking Warfarin (Coumadin) for a Brief Survey

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2014 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-495-4335
Send comments to webmaster@clotcare.org.
Monday, March 27, 2017